Investors expect HHS to include a subset of Medicare Part D drugs in the International Pricing Index demonstration after hearing White House Domestic Policy Council head Joe Grogan speak Tuesday (Oct. 8) at an event in Washington sponsored by the investment bank UBS. Medicare Part D spending dwarfs Part B spending, so adding retail drugs to the international reference pricing scheme would hurt drug industry profits even more. The Trump administration last year announced plans to base prices of Medicare...